| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Palsy | 20 | 2023 | 459 | 4.150 |
Why?
|
| Cartilage, Articular | 30 | 2023 | 1095 | 3.710 |
Why?
|
| Scoliosis | 20 | 2022 | 725 | 2.690 |
Why?
|
| Femur | 19 | 2020 | 1297 | 2.530 |
Why?
|
| Glycosaminoglycans | 18 | 2021 | 624 | 1.990 |
Why?
|
| Hip Dislocation | 5 | 2020 | 244 | 1.560 |
Why?
|
| Fractures, Spontaneous | 4 | 2016 | 230 | 1.400 |
Why?
|
| Tomography, X-Ray Computed | 49 | 2023 | 20130 | 1.380 |
Why?
|
| Spinal Fusion | 14 | 2022 | 1241 | 1.340 |
Why?
|
| Bone Density | 24 | 2023 | 3468 | 1.290 |
Why?
|
| Tensile Strength | 5 | 2011 | 335 | 1.170 |
Why?
|
| Contrast Media | 24 | 2023 | 5300 | 1.170 |
Why?
|
| Thoracoplasty | 3 | 2018 | 15 | 1.150 |
Why?
|
| Osteotomy | 4 | 2016 | 822 | 1.150 |
Why?
|
| Compressive Strength | 10 | 2019 | 169 | 1.140 |
Why?
|
| X-Ray Microtomography | 13 | 2023 | 428 | 1.110 |
Why?
|
| Spine | 11 | 2022 | 1144 | 1.090 |
Why?
|
| Ioxaglic Acid | 6 | 2017 | 30 | 0.940 |
Why?
|
| Elastic Modulus | 7 | 2019 | 214 | 0.940 |
Why?
|
| Osteolysis | 4 | 2013 | 270 | 0.890 |
Why?
|
| Orthopedic Procedures | 7 | 2023 | 1289 | 0.880 |
Why?
|
| Fracture Healing | 4 | 2023 | 427 | 0.830 |
Why?
|
| Bone Diseases, Metabolic | 7 | 2023 | 417 | 0.800 |
Why?
|
| Metacarpophalangeal Joint | 3 | 2019 | 82 | 0.800 |
Why?
|
| Osteoarthritis | 10 | 2021 | 1036 | 0.770 |
Why?
|
| Progeria | 6 | 2020 | 185 | 0.690 |
Why?
|
| Tibia | 7 | 2016 | 1077 | 0.690 |
Why?
|
| Bone and Bones | 17 | 2023 | 2576 | 0.680 |
Why?
|
| Absorptiometry, Photon | 11 | 2023 | 1725 | 0.670 |
Why?
|
| Cervical Vertebrae | 4 | 2020 | 976 | 0.670 |
Why?
|
| Finite Element Analysis | 4 | 2023 | 431 | 0.660 |
Why?
|
| Bone Neoplasms | 3 | 2016 | 2530 | 0.600 |
Why?
|
| Respiratory Insufficiency | 3 | 2020 | 1199 | 0.590 |
Why?
|
| Menisci, Tibial | 2 | 2017 | 269 | 0.590 |
Why?
|
| Biopolymers | 1 | 2018 | 189 | 0.590 |
Why?
|
| Stress, Mechanical | 13 | 2021 | 1686 | 0.580 |
Why?
|
| Osteoporosis | 8 | 2023 | 1579 | 0.580 |
Why?
|
| Polymers | 6 | 2023 | 1621 | 0.580 |
Why?
|
| Models, Animal | 6 | 2021 | 2173 | 0.580 |
Why?
|
| Fractures, Bone | 6 | 2015 | 1947 | 0.570 |
Why?
|
| Cost of Illness | 2 | 2017 | 1860 | 0.560 |
Why?
|
| Hip Joint | 4 | 2019 | 1002 | 0.560 |
Why?
|
| Bone Remodeling | 3 | 2016 | 575 | 0.550 |
Why?
|
| Growth Plate | 4 | 2022 | 274 | 0.540 |
Why?
|
| Femoral Neoplasms | 1 | 2016 | 77 | 0.540 |
Why?
|
| Metacarpal Bones | 2 | 2018 | 73 | 0.530 |
Why?
|
| Thoracic Vertebrae | 4 | 2018 | 608 | 0.530 |
Why?
|
| Immobilization | 1 | 2016 | 236 | 0.520 |
Why?
|
| Cattle | 14 | 2021 | 3922 | 0.500 |
Why?
|
| Iothalamic Acid | 1 | 2014 | 18 | 0.500 |
Why?
|
| Financing, Personal | 1 | 2017 | 308 | 0.500 |
Why?
|
| Movement | 2 | 2019 | 1471 | 0.490 |
Why?
|
| Whales | 3 | 2009 | 30 | 0.490 |
Why?
|
| Spinal Diseases | 4 | 2020 | 538 | 0.480 |
Why?
|
| Lung | 6 | 2018 | 9857 | 0.480 |
Why?
|
| Kyphosis | 2 | 2021 | 237 | 0.460 |
Why?
|
| Acetabulum | 2 | 2020 | 525 | 0.460 |
Why?
|
| Quality of Life | 6 | 2021 | 12802 | 0.440 |
Why?
|
| Rabbits | 11 | 2018 | 4894 | 0.440 |
Why?
|
| Patella | 2 | 2014 | 320 | 0.440 |
Why?
|
| Caregivers | 4 | 2023 | 2095 | 0.430 |
Why?
|
| Mobility Limitation | 2 | 2018 | 409 | 0.420 |
Why?
|
| Ribs | 5 | 2021 | 252 | 0.410 |
Why?
|
| Child | 53 | 2023 | 77709 | 0.410 |
Why?
|
| Tantalum | 3 | 2023 | 56 | 0.410 |
Why?
|
| Physical Stimulation | 3 | 2016 | 525 | 0.400 |
Why?
|
| Cadaver | 6 | 2019 | 1337 | 0.380 |
Why?
|
| Chondrocytes | 6 | 2022 | 804 | 0.370 |
Why?
|
| Braces | 2 | 2005 | 136 | 0.370 |
Why?
|
| Nanotechnology | 3 | 2020 | 710 | 0.370 |
Why?
|
| Disabled Children | 3 | 2017 | 247 | 0.360 |
Why?
|
| Syringomyelia | 2 | 2021 | 64 | 0.360 |
Why?
|
| Oxides | 3 | 2023 | 405 | 0.360 |
Why?
|
| Animals | 60 | 2023 | 168768 | 0.350 |
Why?
|
| Hip | 3 | 2020 | 257 | 0.350 |
Why?
|
| Adolescent | 41 | 2022 | 85779 | 0.330 |
Why?
|
| Fractures, Ununited | 1 | 2010 | 165 | 0.330 |
Why?
|
| Disability Evaluation | 4 | 2018 | 1828 | 0.330 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2021 | 154 | 0.320 |
Why?
|
| Neuromuscular Diseases | 2 | 2022 | 247 | 0.320 |
Why?
|
| Orthopedics | 1 | 2017 | 904 | 0.320 |
Why?
|
| Female | 83 | 2022 | 380193 | 0.320 |
Why?
|
| Tissue Preservation | 1 | 2008 | 182 | 0.320 |
Why?
|
| Bone Development | 3 | 2021 | 483 | 0.310 |
Why?
|
| Fracture Fixation | 5 | 2012 | 354 | 0.310 |
Why?
|
| Femoral Fractures | 2 | 2013 | 376 | 0.300 |
Why?
|
| Lubricants | 2 | 2020 | 31 | 0.300 |
Why?
|
| Rotation | 4 | 2016 | 523 | 0.290 |
Why?
|
| Iodobenzenes | 2 | 2017 | 24 | 0.290 |
Why?
|
| Gadolinium | 2 | 2015 | 952 | 0.290 |
Why?
|
| Ethylenediamines | 2 | 2017 | 48 | 0.290 |
Why?
|
| Humans | 119 | 2023 | 744366 | 0.290 |
Why?
|
| Muscular Atrophy, Spinal | 2 | 2022 | 259 | 0.280 |
Why?
|
| Surgical Wound Infection | 3 | 2021 | 1540 | 0.280 |
Why?
|
| Male | 71 | 2022 | 350115 | 0.280 |
Why?
|
| Osteoarthritis, Knee | 3 | 2020 | 1222 | 0.280 |
Why?
|
| Weight-Bearing | 4 | 2016 | 515 | 0.280 |
Why?
|
| Polyenes | 2 | 2018 | 69 | 0.280 |
Why?
|
| Horses | 7 | 2023 | 304 | 0.280 |
Why?
|
| Ultrasonography | 1 | 2019 | 5984 | 0.280 |
Why?
|
| Child, Preschool | 26 | 2022 | 41005 | 0.280 |
Why?
|
| Humeral Fractures | 3 | 2018 | 272 | 0.270 |
Why?
|
| Lubrication | 3 | 2023 | 20 | 0.260 |
Why?
|
| Subtraction Technique | 1 | 2008 | 525 | 0.260 |
Why?
|
| Dendrimers | 2 | 2020 | 68 | 0.260 |
Why?
|
| Cartilage Diseases | 1 | 2006 | 160 | 0.250 |
Why?
|
| Titanium | 3 | 2015 | 494 | 0.250 |
Why?
|
| Furans | 2 | 2018 | 194 | 0.250 |
Why?
|
| Health Expenditures | 1 | 2017 | 2349 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2013 | 8300 | 0.240 |
Why?
|
| Models, Biological | 5 | 2017 | 9584 | 0.240 |
Why?
|
| Rats | 12 | 2023 | 24252 | 0.240 |
Why?
|
| Ovariectomy | 4 | 2013 | 661 | 0.240 |
Why?
|
| Prosthesis Failure | 2 | 2009 | 1206 | 0.230 |
Why?
|
| Specimen Handling | 1 | 2008 | 694 | 0.230 |
Why?
|
| Respiratory Function Tests | 3 | 2018 | 1617 | 0.230 |
Why?
|
| Sensitivity and Specificity | 10 | 2020 | 14723 | 0.230 |
Why?
|
| Povidone-Iodine | 2 | 2020 | 59 | 0.230 |
Why?
|
| Radiography | 12 | 2018 | 7023 | 0.220 |
Why?
|
| Phosphorylcholine | 1 | 2023 | 162 | 0.220 |
Why?
|
| Parents | 2 | 2023 | 3405 | 0.220 |
Why?
|
| Bone Nails | 3 | 2012 | 219 | 0.220 |
Why?
|
| Bone Screws | 4 | 2020 | 520 | 0.220 |
Why?
|
| Prospective Studies | 17 | 2023 | 53290 | 0.220 |
Why?
|
| Equipment Failure Analysis | 3 | 2009 | 868 | 0.210 |
Why?
|
| Lumbar Vertebrae | 5 | 2022 | 1848 | 0.210 |
Why?
|
| Lamin Type A | 2 | 2020 | 190 | 0.210 |
Why?
|
| Biomedical Research | 1 | 2017 | 3309 | 0.200 |
Why?
|
| Postoperative Complications | 5 | 2020 | 15297 | 0.200 |
Why?
|
| Femur Head | 2 | 2019 | 301 | 0.200 |
Why?
|
| Knee Joint | 3 | 2022 | 1680 | 0.200 |
Why?
|
| Spinal Fractures | 2 | 2022 | 696 | 0.200 |
Why?
|
| Pravastatin | 3 | 2020 | 395 | 0.200 |
Why?
|
| Hemiplegia | 2 | 2018 | 135 | 0.200 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4925 | 0.190 |
Why?
|
| Torque | 3 | 2011 | 124 | 0.190 |
Why?
|
| Stifle | 3 | 2019 | 28 | 0.190 |
Why?
|
| Occipital Bone | 2 | 2020 | 54 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 35425 | 0.190 |
Why?
|
| Retrospective Studies | 27 | 2022 | 77460 | 0.190 |
Why?
|
| Hardness Tests | 2 | 2017 | 9 | 0.190 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2022 | 331 | 0.190 |
Why?
|
| Piperidines | 4 | 2020 | 1602 | 0.190 |
Why?
|
| Young Adult | 13 | 2021 | 56429 | 0.190 |
Why?
|
| Cations | 6 | 2020 | 232 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2282 | 0.180 |
Why?
|
| Porphyromonas gingivalis | 1 | 2000 | 169 | 0.180 |
Why?
|
| Contracture | 1 | 2022 | 224 | 0.180 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2020 | 94 | 0.180 |
Why?
|
| Static Electricity | 2 | 2011 | 263 | 0.180 |
Why?
|
| Synchrotrons | 1 | 2019 | 38 | 0.180 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 18034 | 0.170 |
Why?
|
| Aftercare | 2 | 2023 | 870 | 0.170 |
Why?
|
| Standard of Care | 1 | 2023 | 564 | 0.170 |
Why?
|
| Therapeutic Irrigation | 1 | 2020 | 301 | 0.170 |
Why?
|
| Glycerol | 1 | 2020 | 278 | 0.170 |
Why?
|
| Lung Volume Measurements | 2 | 2018 | 378 | 0.170 |
Why?
|
| Analgesia, Epidural | 1 | 2022 | 326 | 0.160 |
Why?
|
| Viscosupplements | 1 | 2018 | 23 | 0.160 |
Why?
|
| Length of Stay | 4 | 2022 | 6311 | 0.160 |
Why?
|
| Tranexamic Acid | 1 | 2020 | 146 | 0.160 |
Why?
|
| Joint Instability | 4 | 2021 | 792 | 0.160 |
Why?
|
| Hip Fractures | 1 | 2007 | 955 | 0.160 |
Why?
|
| Biocompatible Materials | 5 | 2018 | 1736 | 0.160 |
Why?
|
| Internal Fixators | 2 | 2018 | 188 | 0.160 |
Why?
|
| Arthritis, Experimental | 1 | 2020 | 291 | 0.160 |
Why?
|
| Arthroplasty | 1 | 2020 | 305 | 0.160 |
Why?
|
| Joint Diseases | 1 | 2022 | 479 | 0.160 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2010 | 319 | 0.150 |
Why?
|
| Postoperative Period | 3 | 2021 | 1842 | 0.150 |
Why?
|
| Patient Care Team | 2 | 2019 | 2531 | 0.150 |
Why?
|
| Alveolar Bone Loss | 1 | 2000 | 383 | 0.150 |
Why?
|
| Decompression, Surgical | 2 | 2020 | 594 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2017 | 5791 | 0.150 |
Why?
|
| Fractures, Open | 1 | 2018 | 101 | 0.150 |
Why?
|
| Spondylolisthesis | 1 | 2019 | 163 | 0.150 |
Why?
|
| Muscular Diseases | 1 | 2021 | 555 | 0.150 |
Why?
|
| Friction | 2 | 2017 | 59 | 0.150 |
Why?
|
| Pyridines | 4 | 2020 | 2825 | 0.150 |
Why?
|
| Predictive Value of Tests | 5 | 2016 | 15078 | 0.140 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2012 | 838 | 0.140 |
Why?
|
| Health Status | 2 | 2016 | 4034 | 0.140 |
Why?
|
| Treatment Outcome | 17 | 2021 | 63107 | 0.140 |
Why?
|
| Thumb | 1 | 2018 | 227 | 0.140 |
Why?
|
| Radius Fractures | 2 | 2005 | 501 | 0.140 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2017 | 108 | 0.140 |
Why?
|
| Ossification, Heterotopic | 1 | 2019 | 239 | 0.140 |
Why?
|
| Odontoid Process | 1 | 2016 | 47 | 0.140 |
Why?
|
| Traction | 1 | 2016 | 106 | 0.140 |
Why?
|
| Synovial Fluid | 1 | 2018 | 394 | 0.140 |
Why?
|
| Dependent Ambulation | 1 | 2015 | 13 | 0.140 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 662 | 0.140 |
Why?
|
| Phantoms, Imaging | 5 | 2016 | 2480 | 0.140 |
Why?
|
| Osteomyelitis | 1 | 2020 | 402 | 0.140 |
Why?
|
| Fibroins | 2 | 2006 | 55 | 0.130 |
Why?
|
| Polyethylene Glycols | 3 | 2010 | 1182 | 0.130 |
Why?
|
| Extracellular Fluid | 1 | 2017 | 167 | 0.130 |
Why?
|
| Brain Stem | 2 | 2016 | 846 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2019 | 691 | 0.130 |
Why?
|
| Aged, 80 and over | 12 | 2019 | 57776 | 0.130 |
Why?
|
| Silk | 2 | 2006 | 91 | 0.130 |
Why?
|
| Thorax | 2 | 2010 | 547 | 0.130 |
Why?
|
| Hydrogels | 3 | 2016 | 724 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 972 | 0.130 |
Why?
|
| Critical Pathways | 1 | 2019 | 476 | 0.130 |
Why?
|
| Vibration | 1 | 2016 | 326 | 0.120 |
Why?
|
| Tissue Engineering | 5 | 2017 | 1880 | 0.120 |
Why?
|
| Follow-Up Studies | 10 | 2021 | 39052 | 0.120 |
Why?
|
| Off-Label Use | 2 | 2014 | 169 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 2 | 4 | 2010 | 350 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 2216 | 0.120 |
Why?
|
| Orthopedic Equipment | 1 | 2014 | 22 | 0.120 |
Why?
|
| Pilot Projects | 4 | 2020 | 8319 | 0.120 |
Why?
|
| Age Factors | 5 | 2021 | 18373 | 0.120 |
Why?
|
| Age of Onset | 3 | 2015 | 3270 | 0.120 |
Why?
|
| Fibula | 2 | 2015 | 269 | 0.120 |
Why?
|
| Uncertainty | 2 | 2022 | 735 | 0.120 |
Why?
|
| Calcification, Physiologic | 2 | 2021 | 169 | 0.120 |
Why?
|
| Therapeutic Equipoise | 1 | 2013 | 28 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 639 | 0.110 |
Why?
|
| Somatosensory Cortex | 1 | 2017 | 528 | 0.110 |
Why?
|
| Research Support as Topic | 1 | 2017 | 705 | 0.110 |
Why?
|
| Neoplasms | 2 | 2015 | 21696 | 0.110 |
Why?
|
| Motor Skills | 1 | 2016 | 522 | 0.110 |
Why?
|
| Prostheses and Implants | 4 | 2022 | 1387 | 0.110 |
Why?
|
| Aging | 2 | 2020 | 8664 | 0.110 |
Why?
|
| Bone Density Conservation Agents | 1 | 2020 | 772 | 0.110 |
Why?
|
| Farnesyltranstransferase | 1 | 2012 | 76 | 0.110 |
Why?
|
| Nephrectomy | 2 | 2009 | 1050 | 0.110 |
Why?
|
| Patient Discharge | 2 | 2023 | 3318 | 0.110 |
Why?
|
| Mentors | 1 | 2017 | 631 | 0.110 |
Why?
|
| Salvage Therapy | 1 | 2019 | 1275 | 0.110 |
Why?
|
| Diffusion | 1 | 2014 | 832 | 0.110 |
Why?
|
| Middle Aged | 21 | 2019 | 213390 | 0.100 |
Why?
|
| Nanoparticles | 2 | 2021 | 1905 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2020 | 1401 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2019 | 1533 | 0.100 |
Why?
|
| Reoperation | 3 | 2019 | 4201 | 0.100 |
Why?
|
| Pelvis | 1 | 2016 | 730 | 0.100 |
Why?
|
| Cohort Studies | 7 | 2022 | 40559 | 0.100 |
Why?
|
| External Fixators | 2 | 2005 | 94 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2020 | 1810 | 0.100 |
Why?
|
| Tissue Distribution | 3 | 2017 | 2327 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2017 | 3326 | 0.100 |
Why?
|
| Fractures, Closed | 2 | 2018 | 88 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2016 | 623 | 0.100 |
Why?
|
| Mathematical Computing | 1 | 2011 | 147 | 0.100 |
Why?
|
| Collagen | 3 | 2023 | 2688 | 0.100 |
Why?
|
| Aged | 20 | 2019 | 163288 | 0.100 |
Why?
|
| Adult | 16 | 2019 | 214052 | 0.100 |
Why?
|
| Focus Groups | 1 | 2016 | 1321 | 0.100 |
Why?
|
| Fingers | 1 | 2014 | 513 | 0.100 |
Why?
|
| Metabolic Clearance Rate | 2 | 2012 | 380 | 0.100 |
Why?
|
| Equipment Design | 2 | 2009 | 3582 | 0.090 |
Why?
|
| Triiodobenzoic Acids | 1 | 2010 | 124 | 0.090 |
Why?
|
| Linear Models | 3 | 2015 | 5953 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2021 | 1462 | 0.090 |
Why?
|
| Calcinosis | 1 | 2019 | 1499 | 0.090 |
Why?
|
| Imidazoles | 1 | 2016 | 1206 | 0.090 |
Why?
|
| Surface Properties | 3 | 2023 | 1184 | 0.090 |
Why?
|
| Joints | 2 | 2022 | 327 | 0.090 |
Why?
|
| Risk Factors | 9 | 2020 | 72296 | 0.090 |
Why?
|
| Extremities | 1 | 2015 | 866 | 0.090 |
Why?
|
| Osteogenesis | 3 | 2006 | 1299 | 0.090 |
Why?
|
| Methylene Blue | 1 | 2009 | 155 | 0.080 |
Why?
|
| Osteochondritis | 1 | 2008 | 23 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2018 | 6194 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 644 | 0.080 |
Why?
|
| Range of Motion, Articular | 3 | 2022 | 1578 | 0.080 |
Why?
|
| Peptides | 3 | 2010 | 4410 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2009 | 6459 | 0.080 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2015 | 1632 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2016 | 23336 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 12244 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 547 | 0.080 |
Why?
|
| Bone Substitutes | 2 | 2015 | 229 | 0.080 |
Why?
|
| Oligonucleotides | 2 | 2022 | 572 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15535 | 0.080 |
Why?
|
| Hindlimb | 2 | 2007 | 504 | 0.080 |
Why?
|
| Phenazines | 2 | 2019 | 58 | 0.080 |
Why?
|
| Cross-Sectional Studies | 5 | 2018 | 25039 | 0.080 |
Why?
|
| Organ Size | 2 | 2010 | 2251 | 0.080 |
Why?
|
| Anorexia Nervosa | 1 | 2016 | 1286 | 0.080 |
Why?
|
| Bone Marrow Cells | 2 | 2006 | 2513 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 1671 | 0.080 |
Why?
|
| Risk | 3 | 2020 | 9688 | 0.080 |
Why?
|
| Decamethonium Compounds | 1 | 2006 | 7 | 0.070 |
Why?
|
| Cartilage | 2 | 2022 | 818 | 0.070 |
Why?
|
| Hardness | 2 | 2017 | 36 | 0.070 |
Why?
|
| Fractures, Compression | 1 | 2008 | 133 | 0.070 |
Why?
|
| Carbamates | 1 | 2008 | 196 | 0.070 |
Why?
|
| Respiration Disorders | 1 | 2010 | 371 | 0.070 |
Why?
|
| Angioedema | 1 | 2008 | 187 | 0.070 |
Why?
|
| Hindlimb Suspension | 1 | 2006 | 83 | 0.070 |
Why?
|
| Species Specificity | 2 | 2021 | 2478 | 0.070 |
Why?
|
| Physical Examination | 2 | 2023 | 1237 | 0.070 |
Why?
|
| Pliability | 1 | 2006 | 63 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7182 | 0.070 |
Why?
|
| Biofilms | 1 | 2010 | 617 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2010 | 1101 | 0.070 |
Why?
|
| Epiphyses, Slipped | 1 | 2006 | 87 | 0.070 |
Why?
|
| Brain | 3 | 2020 | 26388 | 0.070 |
Why?
|
| Torsion Abnormality | 1 | 2006 | 93 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 694 | 0.060 |
Why?
|
| Staphylococcus aureus | 2 | 2010 | 1453 | 0.060 |
Why?
|
| Benzamides | 1 | 2010 | 1379 | 0.060 |
Why?
|
| Infant | 8 | 2021 | 35134 | 0.060 |
Why?
|
| Ulna | 1 | 2006 | 133 | 0.060 |
Why?
|
| Extracellular Matrix | 2 | 2010 | 1741 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6539 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2006 | 982 | 0.060 |
Why?
|
| Incidence | 3 | 2020 | 20952 | 0.060 |
Why?
|
| Chickens | 1 | 2006 | 865 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2971 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2020 | 3751 | 0.060 |
Why?
|
| Platelet-Rich Plasma | 1 | 2007 | 177 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2010 | 6366 | 0.060 |
Why?
|
| Knee Injuries | 3 | 2018 | 490 | 0.060 |
Why?
|
| Casts, Surgical | 1 | 2005 | 178 | 0.060 |
Why?
|
| Humerus | 1 | 2006 | 266 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2019 | 21748 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 3 | 2006 | 2007 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 1351 | 0.060 |
Why?
|
| Pelvic Bones | 1 | 2006 | 265 | 0.060 |
Why?
|
| Pediatrics | 1 | 2018 | 3475 | 0.060 |
Why?
|
| Culture Techniques | 1 | 2004 | 554 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1184 | 0.060 |
Why?
|
| Postoperative Care | 2 | 2020 | 1487 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2016 | 10252 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 2020 | 1454 | 0.050 |
Why?
|
| Massachusetts | 1 | 2016 | 8662 | 0.050 |
Why?
|
| Algorithms | 3 | 2019 | 13882 | 0.050 |
Why?
|
| Disease Management | 3 | 2018 | 2460 | 0.050 |
Why?
|
| Bioreactors | 1 | 2004 | 236 | 0.050 |
Why?
|
| Phosphorus | 1 | 2023 | 338 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3508 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2022 | 67 | 0.050 |
Why?
|
| Joint Capsule | 1 | 2022 | 69 | 0.050 |
Why?
|
| Absorbable Implants | 1 | 2004 | 342 | 0.050 |
Why?
|
| Lumbosacral Plexus | 1 | 2022 | 53 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2008 | 804 | 0.050 |
Why?
|
| Chondrogenesis | 1 | 2004 | 247 | 0.050 |
Why?
|
| United States | 4 | 2017 | 69872 | 0.050 |
Why?
|
| Infection Control | 1 | 2009 | 965 | 0.050 |
Why?
|
| Forecasting | 2 | 2014 | 2951 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2007 | 798 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2010 | 4042 | 0.050 |
Why?
|
| Elasticity | 2 | 2018 | 657 | 0.050 |
Why?
|
| Baclofen | 1 | 2022 | 129 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2006 | 645 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2022 | 303 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 3799 | 0.050 |
Why?
|
| Prevotella intermedia | 1 | 2000 | 16 | 0.050 |
Why?
|
| Single-Blind Method | 2 | 2020 | 1590 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1516 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12356 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 13991 | 0.050 |
Why?
|
| Skull | 1 | 2005 | 814 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 3508 | 0.050 |
Why?
|
| Dental Scaling | 1 | 2000 | 102 | 0.050 |
Why?
|
| Stromal Cells | 1 | 2006 | 1355 | 0.050 |
Why?
|
| Inflammation | 1 | 2020 | 10637 | 0.050 |
Why?
|
| Hospitalization | 2 | 2017 | 10259 | 0.050 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2020 | 103 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2023 | 837 | 0.050 |
Why?
|
| Sialoglycoproteins | 3 | 2006 | 318 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2010 | 3424 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2013 | 9955 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 19905 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 17446 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5077 | 0.040 |
Why?
|
| Carotid Arteries | 2 | 2016 | 950 | 0.040 |
Why?
|
| Dental Plaque | 1 | 2000 | 208 | 0.040 |
Why?
|
| Osteopontin | 3 | 2006 | 294 | 0.040 |
Why?
|
| Reflex | 1 | 1981 | 365 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11366 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3759 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 21833 | 0.040 |
Why?
|
| Speech Disorders | 1 | 2020 | 189 | 0.040 |
Why?
|
| Consensus | 2 | 2022 | 2960 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2020 | 145 | 0.040 |
Why?
|
| Wound Healing | 2 | 2008 | 2785 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 3841 | 0.040 |
Why?
|
| Doxycycline | 1 | 2000 | 326 | 0.040 |
Why?
|
| Trapezium Bone | 1 | 2018 | 31 | 0.040 |
Why?
|
| Sheep | 1 | 2021 | 1437 | 0.040 |
Why?
|
| Activities of Daily Living | 2 | 2018 | 2419 | 0.040 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2020 | 250 | 0.040 |
Why?
|
| Time Factors | 4 | 2020 | 40075 | 0.040 |
Why?
|
| Stem Cells | 2 | 2022 | 3567 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 254 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 4851 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2020 | 601 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2018 | 2305 | 0.040 |
Why?
|
| Skull Fractures | 3 | 2006 | 195 | 0.040 |
Why?
|
| Gait | 1 | 2003 | 793 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2020 | 427 | 0.040 |
Why?
|
| Bone Plates | 1 | 2020 | 468 | 0.040 |
Why?
|
| Lumbosacral Region | 1 | 2019 | 310 | 0.040 |
Why?
|
| Prognosis | 3 | 2016 | 29060 | 0.040 |
Why?
|
| Ankle Injuries | 1 | 2001 | 331 | 0.040 |
Why?
|
| Injections, Intra-Articular | 1 | 2018 | 278 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2017 | 235 | 0.040 |
Why?
|
| Logistic Models | 3 | 2019 | 13409 | 0.040 |
Why?
|
| Bed Rest | 1 | 2016 | 84 | 0.040 |
Why?
|
| Rats, Inbred Lew | 1 | 2018 | 1162 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 677 | 0.040 |
Why?
|
| Porosity | 2 | 2008 | 362 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2019 | 566 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2020 | 767 | 0.040 |
Why?
|
| Mice | 6 | 2020 | 81201 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 2017 | 302 | 0.040 |
Why?
|
| Protein Prenylation | 1 | 2016 | 73 | 0.040 |
Why?
|
| Trypsin | 1 | 2017 | 511 | 0.030 |
Why?
|
| Macrophages | 1 | 2011 | 5660 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2019 | 507 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2008 | 1917 | 0.030 |
Why?
|
| Touch Perception | 1 | 2017 | 114 | 0.030 |
Why?
|
| Perception | 1 | 2023 | 1198 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5856 | 0.030 |
Why?
|
| Computers | 1 | 2018 | 612 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2011 | 8949 | 0.030 |
Why?
|
| Periodontitis | 1 | 2000 | 553 | 0.030 |
Why?
|
| Integrin-Binding Sialoprotein | 2 | 2005 | 23 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2019 | 547 | 0.030 |
Why?
|
| Vancomycin | 1 | 2019 | 501 | 0.030 |
Why?
|
| Fibrosis | 1 | 2022 | 2029 | 0.030 |
Why?
|
| Pressure | 1 | 2018 | 1203 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10483 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2020 | 1225 | 0.030 |
Why?
|
| Pain | 1 | 2010 | 4988 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2020 | 1094 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 738 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2000 | 1172 | 0.030 |
Why?
|
| Arthroscopy | 1 | 2021 | 926 | 0.030 |
Why?
|
| Microelectrodes | 1 | 1996 | 303 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 2887 | 0.030 |
Why?
|
| Hospitals | 2 | 2023 | 3954 | 0.030 |
Why?
|
| Orbital Fractures | 1 | 1996 | 110 | 0.030 |
Why?
|
| Biomimetics | 1 | 2016 | 172 | 0.030 |
Why?
|
| Water | 1 | 2021 | 1395 | 0.030 |
Why?
|
| Calcium | 2 | 2019 | 5755 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1301 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 550 | 0.030 |
Why?
|
| Sodium Fluoride | 1 | 2013 | 65 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2008 | 5101 | 0.030 |
Why?
|
| Creatinine | 1 | 2019 | 1919 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2020 | 956 | 0.030 |
Why?
|
| Magnetoencephalography | 1 | 2017 | 624 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2021 | 3914 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3873 | 0.030 |
Why?
|
| Hand | 1 | 2018 | 884 | 0.030 |
Why?
|
| Walking | 1 | 2020 | 1180 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 1256 | 0.030 |
Why?
|
| Motor Activity | 1 | 2003 | 2715 | 0.030 |
Why?
|
| Self Care | 1 | 2018 | 786 | 0.030 |
Why?
|
| Marketing of Health Services | 1 | 2014 | 153 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 1899 | 0.030 |
Why?
|
| Autopsy | 1 | 2016 | 1020 | 0.030 |
Why?
|
| Polymerization | 1 | 2013 | 164 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2019 | 1800 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2020 | 1158 | 0.030 |
Why?
|
| Device Approval | 1 | 2014 | 163 | 0.030 |
Why?
|
| Rheology | 1 | 2013 | 345 | 0.030 |
Why?
|
| Health Care Sector | 1 | 2014 | 194 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 1988 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 1643 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1375 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 867 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2014 | 429 | 0.020 |
Why?
|
| Heart Arrest | 1 | 1981 | 1470 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2011 | 12207 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2428 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1655 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2020 | 1400 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2011 | 129 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2013 | 2255 | 0.020 |
Why?
|
| Brain Abscess | 1 | 1971 | 118 | 0.020 |
Why?
|
| Phosphorus Isotopes | 1 | 2010 | 126 | 0.020 |
Why?
|
| Functional Residual Capacity | 1 | 2010 | 68 | 0.020 |
Why?
|
| Popliteal Artery | 1 | 1992 | 317 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 250 | 0.020 |
Why?
|
| Bone Transplantation | 1 | 2015 | 907 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2015 | 2124 | 0.020 |
Why?
|
| Ethics, Medical | 2 | 2014 | 792 | 0.020 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2014 | 430 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 2031 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 370 | 0.020 |
Why?
|
| Vomiting | 1 | 2012 | 637 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 2088 | 0.020 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 129 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2219 | 0.020 |
Why?
|
| Language | 1 | 2018 | 1471 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2015 | 7730 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2015 | 2110 | 0.020 |
Why?
|
| Informed Consent | 2 | 2014 | 995 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2013 | 885 | 0.020 |
Why?
|
| Observer Variation | 1 | 2014 | 2593 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2000 | 9849 | 0.020 |
Why?
|
| Peptide Library | 1 | 2009 | 349 | 0.020 |
Why?
|
| Aluminum | 1 | 2008 | 152 | 0.020 |
Why?
|
| Seizures | 1 | 2020 | 2859 | 0.020 |
Why?
|
| Psychometrics | 1 | 2017 | 3003 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2018 | 2974 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 2002 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 836 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9735 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2014 | 1011 | 0.020 |
Why?
|
| Durapatite | 1 | 2008 | 161 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3528 | 0.020 |
Why?
|
| X-Rays | 1 | 2008 | 301 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2016 | 2251 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2022 | 9145 | 0.020 |
Why?
|
| Iodine | 1 | 2009 | 286 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 562 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 675 | 0.020 |
Why?
|
| Minerals | 1 | 2008 | 275 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10400 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 2618 | 0.020 |
Why?
|
| Lung Compliance | 1 | 2006 | 195 | 0.020 |
Why?
|
| Anthropometry | 1 | 2011 | 1350 | 0.020 |
Why?
|
| Bombyx | 1 | 2006 | 55 | 0.020 |
Why?
|
| Adsorption | 1 | 2006 | 201 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2012 | 1183 | 0.020 |
Why?
|
| Registries | 1 | 2022 | 8091 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 2539 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6489 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1584 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2737 | 0.020 |
Why?
|
| Body Water | 1 | 2007 | 343 | 0.020 |
Why?
|
| Thoracic Diseases | 1 | 2006 | 97 | 0.020 |
Why?
|
| Drug Implants | 1 | 2006 | 244 | 0.020 |
Why?
|
| Fibronectins | 1 | 2009 | 726 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2453 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 7323 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2007 | 2186 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 816 | 0.020 |
Why?
|
| Diarrhea | 1 | 2012 | 1348 | 0.020 |
Why?
|
| Fatigue | 1 | 2012 | 1531 | 0.020 |
Why?
|
| Joint Prosthesis | 1 | 1987 | 258 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2013 | 2016 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 164 | 0.020 |
Why?
|
| Materials Testing | 1 | 2008 | 867 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2005 | 420 | 0.020 |
Why?
|
| Hydroxyapatites | 1 | 2004 | 75 | 0.020 |
Why?
|
| Body Height | 1 | 2011 | 1578 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1793 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 4933 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8642 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1343 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 16000 | 0.010 |
Why?
|
| Atrophy | 1 | 1988 | 1584 | 0.010 |
Why?
|
| Cell Differentiation | 3 | 2006 | 11486 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13286 | 0.010 |
Why?
|
| Bone Resorption | 1 | 1987 | 723 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2006 | 1032 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2016 | 12025 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16367 | 0.010 |
Why?
|
| Weight Gain | 1 | 2012 | 2293 | 0.010 |
Why?
|
| Light | 1 | 2008 | 1374 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2004 | 378 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2017 | 6670 | 0.010 |
Why?
|
| Reflex, Pupillary | 1 | 1981 | 61 | 0.010 |
Why?
|
| Protons | 1 | 2007 | 1127 | 0.010 |
Why?
|
| Knee Prosthesis | 1 | 1985 | 425 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3611 | 0.010 |
Why?
|
| Cicatrix | 1 | 2007 | 764 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1988 | 1058 | 0.010 |
Why?
|
| Blinking | 1 | 1981 | 138 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 10943 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 1680 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2012 | 3208 | 0.010 |
Why?
|
| Cervical Atlas | 1 | 1978 | 21 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2005 | 3689 | 0.010 |
Why?
|
| Microfluidics | 1 | 2004 | 662 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2004 | 19233 | 0.010 |
Why?
|
| Artifacts | 1 | 2007 | 1904 | 0.010 |
Why?
|
| Eye Movements | 1 | 1981 | 507 | 0.010 |
Why?
|
| Resuscitation | 1 | 1981 | 658 | 0.010 |
Why?
|
| Swine | 1 | 2007 | 5918 | 0.010 |
Why?
|
| Mentally Ill Persons | 1 | 1977 | 126 | 0.010 |
Why?
|
| Maxillary Fractures | 1 | 1996 | 20 | 0.010 |
Why?
|
| Zygomatic Fractures | 1 | 1996 | 37 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4569 | 0.010 |
Why?
|
| Ethmoid Bone | 1 | 1996 | 35 | 0.010 |
Why?
|
| Nasal Bone | 1 | 1996 | 58 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 7282 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 29786 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1988 | 6994 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2007 | 3280 | 0.010 |
Why?
|
| Physicians | 1 | 2013 | 4567 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1988 | 6151 | 0.010 |
Why?
|
| Orbit | 1 | 1996 | 426 | 0.010 |
Why?
|
| Pulse | 1 | 1992 | 229 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7721 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 1977 | 865 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1992 | 597 | 0.010 |
Why?
|
| Aneurysm | 1 | 1992 | 339 | 0.010 |
Why?
|
| Unconsciousness | 1 | 1971 | 263 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1992 | 1107 | 0.010 |
Why?
|
| Foot | 1 | 1992 | 527 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2001 | 3531 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1988 | 6598 | 0.000 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1992 | 793 | 0.000 |
Why?
|
| Angiography | 1 | 1992 | 1639 | 0.000 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1992 | 795 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1971 | 1285 | 0.000 |
Why?
|
| Bone Cements | 1 | 1985 | 325 | 0.000 |
Why?
|
| Dementia | 1 | 1977 | 2518 | 0.000 |
Why?
|
| Paternalism | 1 | 1977 | 46 | 0.000 |
Why?
|
| Minnesota | 1 | 1977 | 344 | 0.000 |
Why?
|
| Social Values | 1 | 1977 | 224 | 0.000 |
Why?
|
| Personal Autonomy | 1 | 1977 | 298 | 0.000 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 1977 | 500 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1985 | 3589 | 0.000 |
Why?
|